Inovio Pharmaceuticals Inc

INO:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:17 AM EST
9.78quote price arrow up+0.06 (+0.62%)
Volume
567
Close
9.72quote price arrow up+0.72 (+8.00%)
Volume
18,891,023
52 week range
3.14 - 33.79

...

Loading . . .

KEY STATS

  • Open9.00
  • Day High9.78
  • Day Low8.93
  • Prev Close9.72
  • 52 Week High33.79
  • 52 Week High Date06/26/20
  • 52 Week Low3.14
  • 52 Week Low Date02/07/20
  • Market Cap1,816.18M
  • Shares Out186.85M
  • 10 Day Average Volume10.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • 1 Year % Change129.25

RATIOS/PROFITABILITY

  • EPS (TTM)-1.35
  • P/E (TTM)-7.19
  • Fwd P/E (NTM)-14.09
  • EBITDA (MRQ)-121.28M
  • ROE (MRQ)-100.52%
  • Revenue (MRQ)2.11M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-8,465.00%
  • Debt To Equity (MRQ)16.58%

EVENTS

  • Earnings Date03/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Inovio Pharmaceuticals Inc News

There is no recent news for this security.

Latest INO News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of...
Simon Benito
Chairman
Jong Kim Ph.D.
Chief Executive Officer
Jacqueline Elizabeth Shea Ph.D.
Chief Operating Officer
Peter Kies
Chief Financial Officer
Address
6769 Mesa Ridge Rd
San Diego, CA
92121-2995
United States